FMP
Biogen Posts Q3 Earnings Beat and Raises 2024 Guidance
Oct 30, 2024 6:52 PM - Davit Kirakosyan(Last modified: Oct 31, 2024 12:45 AM)
Image credit: FMP
Biogen (NASDAQ:BIIB) reported better-than-expected third-quarter results and raised its annual earnings guidance. The biotech firm posted Q3 earnings per share of $4.08, beating Wall Street expectations of $3.77, with revenue reaching $2.47 billion, slightly above the consensus of $2.43 billion.
The company’s multiple sclerosis segment generated $1.05 billion in revenue, close to estimates, while sales of Biogen's Alzheimer’s drug Leqembi rose to $67 million from about $40 million in the prior quarter.
Biogen raised its full-year 2024 EPS guidance to between $16.10 and $16.60, compared to the previous range of $15.75 to $16.25 and above the $16.19 consensus at the midpoint. The company maintained its outlook for a low-single-digit revenue decline compared to 2023, with core pharmaceutical revenue expected to stay roughly flat.
Other Blogs
May 14, 2024 11:41 AM - Sanzhi Kobzhan
The easiest way to calculate stock’s target price and why the target price is important.
A stock's target price, also known as its fair value, is an indication of what a share can cost based on the company’s forecasted financial statements. It is important to know a stock's fair value to find undervalued stocks with great growth potential. Let's consider how investment analysts calculat...
May 27, 2024 3:30 PM - Rajnish Katharotiya
The best 5 GPU stocks other than NVDA
In the ever-evolving world of technology, certain sectors have consistently demonstrated exceptional growth and innovation. The graphics processing units (GPUs) industry is one such sector, offering investors a golden opportunity for potentially high returns. In this blog, we'll delve into why inves...
Jun 6, 2024 2:47 AM - Parth Sanghvi
ROE vs ROA: Which Metric is More Important for Investors?
ROE vs. ROA: Which Metric is More Important for Investors? When evaluating a company's financial performance, investors often rely on various metrics to gauge profitability and efficiency. Two commonly discussed metrics are Return on Equity (ROE) and Return on Assets (ROA). Understanding the diff...
